No Oral Formulation Available
Zosyn (piperacillin/tazobactam) is only available as an intravenous formulation and has no oral (per os) form. 1
Why No Oral Form Exists
The FDA drug label explicitly describes Zosyn as "an injectable antibacterial combination product consisting of the semisynthetic antibacterial piperacillin sodium and the beta-lactamase inhibitor tazobactam sodium for intravenous administration" 1. All formulations listed are premixed frozen solutions for IV infusion in concentrations of 2.25 g/50 mL, 3.375 g/50 mL, and 4.5 g/100 mL 1.
Clinical Implications
Hospital-based therapy only: Because Zosyn requires IV administration, patients needing this antibiotic must receive it in settings where IV access and monitoring are available (hospitals, infusion centers, or home health with IV capabilities).
No step-down oral option: Unlike some beta-lactam antibiotics (such as amoxicillin-clavulanic acid which has both IV and oral forms), piperacillin/tazobactam cannot be transitioned to an oral formulation for outpatient completion of therapy 2.
Alternative oral agents needed: When patients are ready for discharge but still require antibiotic therapy, you must switch to an entirely different oral antibiotic based on culture sensitivities and infection type. Guidelines recommend various oral alternatives depending on the specific infection (e.g., amoxicillin-clavulanic acid for skin/soft tissue infections, fluoroquinolones for certain gram-negative infections) 2.
Common Pitfall
Do not confuse piperacillin/tazobactam with amoxicillin/clavulanic acid (Augmentin)—while both are beta-lactam/beta-lactamase inhibitor combinations, only the latter has an oral formulation. Piperacillin/tazobactam's pharmacokinetic properties and molecular structure make it unsuitable for oral absorption.